IperionX Quadruples Titanium Powder Output, but Army Deal and Cash Position Come With Asterisks

IperionX's September-quarter report, released today, puts two headline numbers side by side: titanium powder production that jumped to 8.7 tonnes from 1.4 tonnes in the June quarter, and a fresh US Army award with a base value of $18.5 million. Both look like progress. Neither tells the full story on its own.

The production figure is the more straightforward of the two. Output of HAMR titanium powder rose sharply quarter over quarter, and that matters more than any capacity claim because it reflects what the company actually made rather than what its equipment could theoretically produce. Validated plant performance describes a ceiling; the quarterly tonnage describes reality. At quarter-end, IperionX held 19 tonnes of finished powder and 207 tonnes of titanium scrap — inventory that rounds out the ramp-up picture but says nothing on its own about sales.

The Army Contract: Base Value Is Not Funded Value

The second Army order carries a base value of $18.5 million, of which $11.5 million is funded up front. Options could lift the total to as much as $25.4 million, while the ceiling on the overarching SBIR contract sits at $99 million. Those are three distinct figures, and treating any of them as guaranteed cash would misread the filing. The funded portion is what counts; options expand the possible scope but do not substitute for confirmed financing, and the SBIR ceiling describes a contract framework rather than work already awarded.

Cash, Refundable Government Money, and Why They Differ

IperionX ended the September quarter with $63 million in cash. Add $33.7 million in committed, refundable US government funding and the company reports total liquidity of roughly $96.7 million. That combined figure is not free cash. The government component is reimbursable financing and has to be assessed separately from the bank balance — a distinction that matters when judging how the production buildout will be paid for.

The cash position was bolstered by the July US offering, which raised about $50 million gross and $46.1 million net. Against that, operations consumed $12.6 million during the September quarter. Capital inflow and ongoing funding needs therefore sit side by side: a stronger cash balance is not evidence of a self-funding operation, though it does give IperionX a sturdier base for the next stage of the ramp.

Building Toward 1,400 Tonnes

The expansion now under way targets annual capacity of 1,400 tonnes. Supporting it are grants of $47.1 million under the IBAS program and $12.7 million from the DPA Title III program. The funding accompanies a concrete buildout, but planned capacity is not the same as production already achieved — a gap that stays relevant when weighing operational progress.

Taken together, the quarter shows a company making tangible strides in output and order flow, backed by a fuller treasury and state support for expansion. The measure for investors is whether those advances hold up against cash burn and the portion of contracts actually funded — not against nameplate capacity or a maximum contract value.